| Understanding COVID-19 vaccine hesitancy and resistance: another challenge in cancer patients N Mejri, Y Berrazega, E Ouertani, H Rachdi, M Bohli, L Kochbati, ... Supportive Care in Cancer 30, 289-293, 2022 | 72 | 2022 |
| Assessing the financial toxicity in Tunisian cancer patients using the Comprehensive Score for Financial Toxicity (COST) N Mejri, Y Berrazega, R Boujnah, H Rachdi, H El Benna, S Labidi, ... Supportive Care in Cancer 29, 4105-4111, 2021 | 17 | 2021 |
| Association between epidemiological and clinico-pathological features of breast cancer with prognosis, family history, Ki-67 proliferation index and survival in Tunisian breast … N Mighri, N Mejri, M Boujemaa, Y Berrazega, H Rachdi, H El Benna, ... Plos one 17 (9), e0269732, 2022 | 15 | 2022 |
| Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of BRCA Related Cancers Y Hamdi, N Mighri, M Boujemaa, N Mejri, S Ben Nasr, M Ben Rekaya, ... Frontiers in Oncology 11, 674965, 2021 | 9 | 2021 |
| Analysis of prognostic factors of nephroblastoma in a Tunisian cohort. R Doghri, A Aloui, Y Berrazaga, N Boujelbene, M Driss, I Abess, F Fdhila, ... La Tunisie Médicale 96 (3), 193-202, 2018 | 6 | 2018 |
| Translation and Validation of the Comprehensive Score of Financial Toxicity for Cancer Patients Into Arabic. N Mejri, H Rachdi, A Mnif, Y Berrazega, HE Benna, S Labidi, H Boussen Journal of Nursing Measurement 30 (4), 2022 | 5 | 2022 |
| Acute pancreatitis secondary to tamoxifen-associated hypertriglyceridemia: A clinical update MHN Goraya, EH Abbasi, MK Amin, F Inayat, MJ Ashraf, M Qayyum, ... Journal of Oncology Pharmacy Practice 29 (1), 218-225, 2023 | 3 | 2023 |
| Breast cancer T1 in an emerging country: 325 Tunisian cases. Y Berrazaga, Y Yahyaoui, A Hamdi, F Letaief, Z Ghodhbani, A Gabsi, ... Breast Journal 26 (12), 2020 | 3 | 2020 |
| Breast angiosarcoma: a case report A Mouna, B Yosra, A Olfa, M Khadija, G Amor, M Amel Int J Case Rep Images 8 (10), 643-647, 2017 | 3 | 2017 |
| Amenorrhea and elevated βhuman chorionic gonadotropin of unknown origin: An unexpected location of choriocarcinoma IB Abdallah, M Mlika, Y Berrazega, N Mejri, H Rachdi, H El Benna, ... Gynecologic Oncology Reports 36, 100746, 2021 | 2 | 2021 |
| Complete clinical response after induction chemotherapy followed by chemoradiotherapy in nasopharyngeal carcinoma: Impact on oncologic outcomes L Feryel, B Yosra, A Mouna, M Khadija, M Amina, Y Yosra, C Nesrine, ... chemotherapy 1, 2, 2017 | 2 | 2017 |
| Intimate partner violence after cancer diagnosis: an SOS call N Mejri, I Lajnef, Y Berrazega, H Rachdi, M Bohli, L Kochbati, B Hamouda Supportive care in cancer 31 (2), 103, 2023 | 1 | 2023 |
| Docetaxel monotherapy induces necrotic acute pancreatitis I Ben Abdallah, Y Berrazega, H Rachdi, N Mejri, H Neji, N Daoud, ... Journal of Oncology Pharmacy Practice 28 (6), 1446-1449, 2022 | 1 | 2022 |
| Identification of BRCA2 Cis Double Heterozygous Breast Cancer Cases Using Whole Exome Sequencing: Phenotypic Expression and Impact on Personalized … Y Hamdi, M Boujemaa, N Mighri, N Mejri, O Jaidane, S Ben Nasr, ... Frontiers in Genetics 12, 674990, 2021 | 1 | 2021 |
| Cognitive complaints during breast cancer endocrine therapy: aromatase inhibitors versus tamoxifen IB Abdallah, H Rachdi, N Mejri, Y Berrazega, S Laabidi, H Boussen BMJ Supportive & Palliative Care, 2022 | | 2022 |
| Oral Communication Abstracts of the 18th Pan Arab Cancer Congress. TUNISIA. April 19-21, 2018 M Benna, M Slimane, W Smaoui, K Syrjanen, A Belaid, H Bouaziz, ... La Tunisie medicale 96 (4), 183-258, 2018 | | 2018 |
| Complete Clinical Response after Induction Chemotherapy Followed by Chemoradiotherapy in Nasopharyngeal Carcinoma: Impact on Oncologic Outcomes. J Cancer Sci Clin Oncol 4 (2 … F Letaief, Y Berrazaga, M Ayadi, K Meddeb, A Mokrani Keywords: Induction chemotherapy, 2017 | | 2017 |
